Silverfin false false 31/08/2025 01/09/2024 31/08/2025 P Brooks 31/08/2021 C Chan 31/08/2021 17 May 2026 The principal activity of the company in the year under review was that of property investment and letting. 13594112 2025-08-31 13594112 bus:Director1 2025-08-31 13594112 bus:Director2 2025-08-31 13594112 2024-08-31 13594112 core:CurrentFinancialInstruments 2025-08-31 13594112 core:CurrentFinancialInstruments 2024-08-31 13594112 core:ShareCapital 2025-08-31 13594112 core:ShareCapital 2024-08-31 13594112 core:RetainedEarningsAccumulatedLosses 2025-08-31 13594112 core:RetainedEarningsAccumulatedLosses 2024-08-31 13594112 core:FurnitureFittings 2024-08-31 13594112 core:FurnitureFittings 2025-08-31 13594112 bus:OrdinaryShareClass1 2025-08-31 13594112 2024-09-01 2025-08-31 13594112 bus:FilletedAccounts 2024-09-01 2025-08-31 13594112 bus:SmallEntities 2024-09-01 2025-08-31 13594112 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 13594112 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 13594112 bus:Director1 2024-09-01 2025-08-31 13594112 bus:Director2 2024-09-01 2025-08-31 13594112 core:FurnitureFittings core:TopRangeValue 2024-09-01 2025-08-31 13594112 2023-09-01 2024-08-31 13594112 core:FurnitureFittings 2024-09-01 2025-08-31 13594112 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 13594112 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 13594112 (England and Wales)

MEDC LIMITED

Unaudited Financial Statements
For the financial year ended 31 August 2025
Pages for filing with the registrar

MEDC LIMITED

Unaudited Financial Statements

For the financial year ended 31 August 2025

Contents

MEDC LIMITED

COMPANY INFORMATION

For the financial year ended 31 August 2025
MEDC LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 August 2025
DIRECTORS P Brooks
C Chan
REGISTERED OFFICE C/O S&W Partners (Manchester) Limited
Pall Mall
1 Pollen Square
59 King Street
Manchester
M2 4PD
United Kingdom
COMPANY NUMBER 13594112 (England and Wales)
ACCOUNTANT S&W Partners (Manchester) Limited
3rd Floor Northern Assurance
Albert Square
9/21 Princess Street
Manchester
M2 4DN
MEDC LIMITED

BALANCE SHEET

As at 31 August 2025
MEDC LIMITED

BALANCE SHEET (continued)

As at 31 August 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 416 826
Investment property 4 373,483 373,483
373,899 374,309
Current assets
Debtors 5 1,371 721
Cash at bank and in hand 6 16,750 7,372
18,121 8,093
Creditors: amounts falling due within one year 7 ( 371,558) ( 370,744)
Net current liabilities (353,437) (362,651)
Total assets less current liabilities 20,462 11,658
Net assets 20,462 11,658
Capital and reserves
Called-up share capital 8 120 120
Profit and loss account 20,342 11,538
Total shareholders' funds 20,462 11,658

For the financial year ending 31 August 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of MEDC Limited (registered number: 13594112) were approved and authorised for issue by the Board of Directors on 17 May 2026. They were signed on its behalf by:

P Brooks
Director
MEDC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2025
MEDC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

MEDC Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Northern Assurance Buildings, 9-21 Princess Street, Manchester, M2 4DN, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

Going concern

As at 31 August 2025 the company had net current liabilities of £353,437 (2024 - £362,651). The company is dependent on the continued support of its directors who have confirmed their commitment to continue to provide the necessary support as long as the company needs it.

On this basis the directors consider it appropriate to prepare the financial statements on a going concern basis. The financial statements do not include any adjustments that might be necessary if the directors were not to provide further support.

Turnover

Turnover represents rents receivable by the company.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Fixtures and fittings 3 years straight line
Investment property

Investment property is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at each reporting date with changes in fair value recognised in profit or loss. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.

The fair value is determined annually by the directors, on an open market value for existing use basis.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Fixtures and fittings Total
£ £
Cost
At 01 September 2024 1,987 1,987
At 31 August 2025 1,986 1,986
Accumulated depreciation
At 01 September 2024 1,161 1,161
Charge for the financial year 409 409
At 31 August 2025 1,570 1,570
Net book value
At 31 August 2025 416 416
At 31 August 2024 826 826

4. Investment property

Investment property
£
Cost
As at 01 September 2024 373,483
As at 31 August 2025 373,483

The investment properties are shown at cost. The directors believe that cost is not materially different to the open market value of the property at 31 August 2025.

5. Debtors

2025 2024
£ £
Other debtors 1,371 721

6. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 16,750 7,372

7. Creditors: amounts falling due within one year

2025 2024
£ £
Taxation and social security 2,161 1,439
Other creditors 369,397 369,305
371,558 370,744

8. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
120 Ordinary shares of £ 1.00 each 120 120